US Targets Vein Treatment's Marketing In FCA Suit

Law360, New York (December 13, 2012, 9:31 PM EST) -- The U.S. government on Wednesday filed an intervening complaint in a False Claims Act suit in Texas federal court accusing Vascular Solutions Inc. of defrauding Medicare and other government health programs out of $20 million through kickbacks and off-label promotion of its endovenous laser therapy products.

The U.S. government accused VSI of promoting its Vari-Lase device for the ablation of perforator veins, despite never having been approved for such an indication by the FDA.

“VSI did so notwithstanding the fact that it had attempted to and...
To view the full article, register now.